Long ‐term clinical outcomes from real‐world experience of left atrial appendage exclusion with LARIAT device

ConclusionsLong term data from routine clinical practice from our study suggests that LAA exclusion with LARIAT device is an effective treatment in management of non ‐valvular AF patients with high risk of stroke, bleeding and mortality. Further randomized trials, such as aMAZE, will provide more insight in this expanding field.This article is protected by copyright. All rights reserved.

Source: Journal of Cardiovascular Electrophysiology - October 8, 2019 Category: Cardiology Authors: Valay Parikh, Krzysztof Bartus, Radoslaw Litwinowicz, Mohit K. Turagam, Jerzy Sadowski, Boguslaw Kapelak, Magdalena Bartus, Jakub Podolec, Maciej Brzezinski, Dan Musat, Abdi Rasekh, Suneet Mittal, Jie Cheng, Nitish Badhwar, Randall Lee, Dha Tags: ORIGINAL ‐ CLINICAL Source Type: research